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correlation between the prosthesis and this type of lymphoma. Surgical management seems to be essential for diagnosis and
treatment. Given the lack of data, treatment decisions need to be individualized.
http://dx.doi.org/10.1016/j.rpor.2013.03.334
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Introduction. The etiology lymphomatous is especially rare in this location. In 85% of cases of Hodgkin’s disease (HD) presents with
palpable lymphadenopathy. Most seated in the neck (60–80%), with a percentage epitrochlear <2%. Epitrochlear involvement in
Hodgkin disease is an uncommon event reported rarely in the literature. There is currently no clear consensus on the optimal
treatment technique for HD with epitrochlear involvement. Early-stage favorable HD, it may choose to perform after sequential
treatment with QT-RT or RT exclusive. Clinical case: 43-year-old-man with hypertension treated without other diseases. In
August 2011 have a growth on his left forearm without B symptoms, that after excision biopsy-diagnosed HD with lymphocyte-
predominant presence of adenopathy epitrochlear. It takes up study extension revealed the presence of axillary lymph nodes in
left, infraclavicular, supraclavicular and left submandibular. Diagnosed with HD lymphocyte-predominant E-IIA, chemotherapy
starts with ABDV scheme, receiving a total of 2 cycles and then given external radiotherapy with photons ALE 6 and 18MV in
region of left forearm epitrochlear more margin and cervical areas (Ia-IV), left axillary and supraclavicular fossa for a total of
30Gy. It takes a special locking system to place the forearm up and ensure proper coverage epitrochlear. The patient is being
monitored in the service of Hematology and Radiation Oncology. In PET-CT assessment is objective complete metabolic response
with no signs of tumor viability. Currently, the patient remains in complete response.
Conclusions. Epitrochlear involvement in HD is a rare event, with only limited data available describing this unique presentation,
its treatment, and long term outcome. In this case, since it was a stage HD early favorable, it was decided to chemotherapy and
radiotherapy to 30Gy sequentially, achieving complete tumor response.
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Introduction. Overall prognosis of patients with early-stage Hodgkin lymphoma is excellent, with 10 year overall survival >80%, but
second tumors remain the most important late effect, mostly breast cancer in female patients, so is of paramount importance
to decrease breast dose delivered in these patients. Traditionally these patients have been treated with APPA 3DRT. PURPOSE:
To evaluate different treatment options adopted in our department in order to better treat large volumes while sparing critical
organs.
Materials and methods. There is growing dosimetric evidence that highly conformal radiotherapy may spare critical organs in
lymphomas involving largemediastinal volumes, reducing radiationdose to lung, heart andbreast. To explore possible dosimetric
advantages of IMRT, 3 different options have been evaluated paying attention to improve conformality and minimizing low
radiation doses: 3DRT MLC, APPA Irregular Surface Compensator IMRT with manual ﬂuence shaping and VMAT.
Results. Decisions about choice of one technique over another were taken depending on the beneﬁcial effect in sparing surround-
ing normal tissue while preserving the precision of dose distribution. Illustrative examples of each option are included together
with the decision criteria.
Conclusions. To show our preliminary experience for lymphoma treatment with modern radiation techniques, initiating an open
debate for better technique choice. VMAT results in superior level of homogeneity and sparing organs at risk but increased low
radiation doses. Longer follow-up is needed to verify possible late toxicities.
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Introduction. Mycosis fungoides (MF) is the most frequent type of cutaneous T-cell lymphoma (CTCL) and is also frequently treated
withRT.A studyof very low-dose radiotherapy formycosis fungoideswith 8Gy in two fractions showed that the complete response
rate was 92%.
Purpose. To determine in our hospital that low-dose palliative radiotherapy is a useful and effective schedule of treatment.
